首页> 外文期刊>Science China Life Sciences >Arrhythmogenic mechanisms in ryanodine receptor channelopathies
【24h】

Arrhythmogenic mechanisms in ryanodine receptor channelopathies

机译:ryanodine受体通道病的心律失常机制

获取原文
           

摘要

Ryanodine receptors (RyRs) are the calcium release channels of sarcoplasmic reticulum (SR) that provide the majority of calcium ions (Ca2+) necessary to induce contraction of cardiac and skeletal muscle cells. In their intracellular environment, RyR channels are regulated by a variety of cytosolic and luminal factors so that their output signal (Ca2+) induces finely-graded cell contraction without igniting cellular processes that may lead to aberrant electrical activity (ventricular arrhythmias) or cellular remodeling. The importance of RyR dysfunction has been recently highlighted with the demonstration that point mutations in RYR2 , the gene encoding for the cardiac isoform of the RyR (RyR2), are associated with catecholaminergic polymorphic ventricular tachycardia (CPVT), an arrhythmogenic syndrome characterized by the development of adrenergically-mediated ventricular tachycardia in individuals with an apparently normal heart. Here we summarize the state of the field in regards to the main arrhythmogenic mechanisms triggered by RyR2 channels harboring mutations linked to CPVT. Most CPVT mutations characterized to date endow RyR2 channels with a gain of function, resulting in hyperactive channels that release Ca2+ spontaneously, especially during diastole. The spontaneous Ca2+ release is extruded by the electrogenic Na+/Ca2+ exchanger, which depolarizes the external membrane (delayed afterdepolarization or DAD) and may trigger untimely action potentials. However, a rare set of CPVT mutations yield RyR2 channels that are intrinsically hypo-active and hypo-responsive to stimuli, and it is unclear whether these channels release Ca2+ spontaneously during diastole. We discuss novel cellular mechanisms that appear more suitable to explain ventricular arrhythmias due to RyR2 loss-of-function mutations. Keywords ryanodine receptors CPVT sarcoplasmic reticulum cardiac arrhythmias.
机译:Ryanodine受体(RyRs)是肌浆网(SR)的钙释放通道,可提供诱导心肌和骨骼肌细胞收缩所需的大部分钙离子(Ca 2 + )。在其细胞内环境中,RyR通道受到多种胞质和腔因子的调节,因此其输出信号(Ca 2 + )诱导细微的细胞收缩,而不会点燃可能导致异常电信号的细胞过程。活动(室性心律失常)或细胞重塑。最近,RyR功能障碍的重要性得到了证明,即RYR2的点突变是RyR的心脏同工型(RyR2)的编码基因,与儿茶酚胺能性多形性室性心动过速(CPVT)有关,CPVT是一种以发展为特征的心律失常综合征心脏正常的个体中肾上腺素介导的室性心动过速的发生。在这里,我们总结了有关RyR2通道引发的主要心律失常机制的领域状态,RyR2通道具有与CPVT相关的突变。迄今为止大多数特征性的CPVT突变赋予RyR2通道功能增强,导致过度活跃的通道自发释放Ca 2 + ,特别是在舒张期。自发的Ca 2 + 释放被电化的Na + / Ca 2 + 交换剂挤出,该交换剂使外膜去极化(去极化或DAD后延迟) ),并可能触发不合时宜的动作电位。然而,一组罕见的CPVT突变会产生RyR2通道,这些通道本质上是低活性的,并且对刺激反应不足,尚不清楚这些通道是否在舒张期自发释放Ca 2 + 。我们讨论了新型细胞机制,由于RyR2功能缺失突变,这种机制似乎更适合解释室性心律失常。关键词ryanodine受体; CPVT;肌浆网;心律失常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号